Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in transforming the treatment pf cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.
Stock Price Prediction
Update at 5:00pm EST
6.643 - 6.707
6.707 - 6.745
6.02 - 6.1
6.1 - 6.148
6.217 - 6.349
6.349 - 6.429
as of: 2020-01-24 4:33:12 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.JNCE has closed below the lower band by 3.2%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 14% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
2019-12-20 Is Jounce Therapeutics (JNCE) Stock Outpacing Its Medical Peers This Year? Is (JNCE) Outperforming Other Medical Stocks This Year?
2019-12-05 Is the Options Market Predicting a Spike in Jounce Therapeutics (JNCE) Stock? Investors need to pay close attention to Jounce Therapeutics (JNCE) stock based on the movements in the options market lately.
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.